Cargando…
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Schizophrenia, which affects around 1% of the world’s population, has been described as a complex set of symptoms triggered by multiple factors. However, the exact background mechanisms remain to be explored, whereas therapeutic agents with excellent effectivity and safety profiles have yet to be de...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832375/ https://www.ncbi.nlm.nih.gov/pubmed/31619006 http://dx.doi.org/10.3390/molecules24203709 |